Frontier biology AI lab building a foundation model for microbial communities to predict drug toxicity and efficacy.
Anto is a frontier biology AI lab making the gut microbiome computable using quality-aware sparsification and large multimodal foundation models trained on 100,000+ interventional trajectories. The platform predicts drug toxicity and efficacy variations driven by microbiome differences across diverse populations, helping pharma companies address a root cause of most drug failures. It supports causal reasoning, ecosystem dynamic forecasting, and inverse design of microbial therapies with lab-in-the-loop validation. Anto is a product of Anto Biosciences.